199 related articles for article (PubMed ID: 25050904)
1. Growth hormone signaling in muscle and adipose tissue of obese human subjects: associations with measures of body composition and interaction with resveratrol treatment.
Clasen BF; Poulsen MM; Escande C; Pedersen SB; Møller N; Chini EN; Jessen N; Jørgensen JO
J Clin Endocrinol Metab; 2014 Dec; 99(12):E2565-73. PubMed ID: 25050904
[TBL] [Abstract][Full Text] [Related]
2. GH signaling in skeletal muscle and adipose tissue in healthy human subjects: impact of gender and age.
Vestergaard PF; Vendelbo MH; Pedersen SB; Juul A; Ringgard S; Møller N; Jessen N; Jørgensen JO
Eur J Endocrinol; 2014 Nov; 171(5):623-31. PubMed ID: 25163724
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade.
Nielsen C; Gormsen LC; Jessen N; Pedersen SB; Møller N; Lund S; Jørgensen JO
J Clin Endocrinol Metab; 2008 Jul; 93(7):2842-50. PubMed ID: 18460563
[TBL] [Abstract][Full Text] [Related]
4. Impact of fasting on growth hormone signaling and action in muscle and fat.
Moller L; Dalman L; Norrelund H; Billestrup N; Frystyk J; Moller N; Jorgensen JO
J Clin Endocrinol Metab; 2009 Mar; 94(3):965-72. PubMed ID: 19066303
[TBL] [Abstract][Full Text] [Related]
5. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.
Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA
J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone signaling and action in obese versus lean human subjects.
Høgild ML; Bak AM; Pedersen SB; Rungby J; Frystyk J; Møller N; Jessen N; Jørgensen JOL
Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E333-E344. PubMed ID: 30576246
[TBL] [Abstract][Full Text] [Related]
7. GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus.
Jørgensen JO; Jessen N; Pedersen SB; Vestergaard E; Gormsen L; Lund SA; Billestrup N
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E899-905. PubMed ID: 16757551
[TBL] [Abstract][Full Text] [Related]
8. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
[TBL] [Abstract][Full Text] [Related]
9. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status.
Savastano S; Di Somma C; Colao A; Barrea L; Orio F; Finelli C; Pasanisi F; Contaldo F; Tarantino G
Growth Horm IGF Res; 2015 Feb; 25(1):28-33. PubMed ID: 25466907
[TBL] [Abstract][Full Text] [Related]
10. Reduction of adiposity with prolonged growth hormone treatment in old obese rats: effects on glucose handling and early insulin signaling.
Johansen T; Laurino C; Barreca A; Malmlöf K
Growth Horm IGF Res; 2005 Feb; 15(1):55-63. PubMed ID: 15701573
[TBL] [Abstract][Full Text] [Related]
11. Increased SULT1E1 activity in HepG2 hepatocytes decreases growth hormone stimulation of STAT5b phosphorylation.
Li L; He D; Wilborn TW; Falany JL; Falany CN
Steroids; 2009 Jan; 74(1):20-9. PubMed ID: 18831980
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.
Franco C; Brandberg J; Lönn L; Andersson B; Bengtsson BA; Johannsson G
J Clin Endocrinol Metab; 2005 Mar; 90(3):1466-74. PubMed ID: 15598680
[TBL] [Abstract][Full Text] [Related]
13. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
Bouhours-Nouet N; Gatelais F; Boux de Casson F; Rouleau S; Coutant R
J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
[TBL] [Abstract][Full Text] [Related]
14. Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus Somatostatin Analog Treatment.
Dal J; Høyer KL; Pedersen SB; Magnusson NE; Bjerring P; Frystyk J; Møller N; Jessen N; Jørgensen JO
J Clin Endocrinol Metab; 2016 Oct; 101(10):3716-3723. PubMed ID: 27466699
[TBL] [Abstract][Full Text] [Related]
15. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
[TBL] [Abstract][Full Text] [Related]
16. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.
Jørgensen JO; Vahl N; Hansen TB; Thuesen L; Hagen C; Christiansen JS
Clin Endocrinol (Oxf); 1996 Dec; 45(6):681-8. PubMed ID: 9039333
[TBL] [Abstract][Full Text] [Related]
18. Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients.
Richelsen B; Pedersen SB; Kristensen K; Børglum JD; Nørrelund H; Christiansen JS; Jørgensen JO
Metabolism; 2000 Jul; 49(7):906-11. PubMed ID: 10910003
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I response to a single bolus of growth hormone is increased in obesity.
Gleeson HK; Lissett CA; Shalet SM
J Clin Endocrinol Metab; 2005 Feb; 90(2):1061-7. PubMed ID: 15522943
[TBL] [Abstract][Full Text] [Related]
20. Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone.
Ellis KJ; Lee PD; Pivarnik JM; Bukar JG; Gesundheit N
J Clin Endocrinol Metab; 1996 Aug; 81(8):3033-8. PubMed ID: 8768870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
